SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-053135
Filing Date
2021-10-18
Accepted
2021-10-18 07:32:57
Documents
13
Period of Report
2021-10-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149002-8k_biomxinc.htm   iXBRL 8-K 43296
  Complete submission text file 0001213900-21-053135.txt   271150

Data Files

Seq Description Document Type Size
2 XBRL DEFINITION FILE phge-20211018_def.xml EX-101.DEF 27335
3 XBRL LABEL FILE phge-20211018_lab.xml EX-101.LAB 37938
4 XBRL PRESENTATION FILE phge-20211018_pre.xml EX-101.PRE 25949
5 XBRL SCHEMA FILE phge-20211018.xsd EX-101.SCH 4174
6 EXTRACTED XBRL INSTANCE DOCUMENT ea149002-8k_biomxinc_htm.xml XML 7087
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 211327331
SIC: 2836 Biological Products, (No Diagnostic Substances)